- Q3 2026 revenue reported at $83.9M, with MRD revenue expanding 28% YoY (44% ex-milestones).
- Reached net profitability earlier than anticipated with Q3 net income of $2.88M ($0.02 EPS).
- Cash balance improved with total assets rising to $683.1M compared to $512.7M in prior period.
Why is $ADPT moving today? · SEC 8-K archive
$ADPT SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $ADPT: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $ADPT filing catalyst
Why did $ADPT trigger an AI stock catalyst alert?
$ADPT triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.5/10). Headline: Adaptive Biotechnologies Reports Q3 2026 Profitability Ahead of Schedule, EPS $0.02. Key points: - Q3 2026 revenue reported at $83.9M, with MRD revenue expanding 28% YoY (44% ex-milestones). - Reached net profitability earlier than anticipated with Q3 net income of $2.88M ($0.02 EPS). - Cash balance improved with total assets rising to $683.1M compared to $512.7M in prior period.
How did $ADPT stock react after the SEC filing?
After the SEC 8-K for $ADPT, observed market reaction: T0 price $26.71. Past moves do not guarantee future results.
Where can I get real-time $ADPT SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $ADPT via Telegram and the VIP Web Terminal from €10/month.